Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zogenix Inc (ZGNX)

Zogenix Inc (ZGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,500,136
  • Shares Outstanding, K 56,227
  • Annual Sales, $ 81,690 K
  • Annual Income, $ -227,410 K
  • 60-Month Beta 0.89
  • Price/Sales 18.07
  • Price/Cash Flow N/A
  • Price/Book 8.35
Trade ZGNX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.27
  • Most Recent Earnings $-0.98 on 02/28/22
  • Latest Earnings Date 02/24/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate -0.86
  • Number of Estimates 2
  • High Estimate -0.81
  • Low Estimate -0.90
  • Prior Year -1.00
  • Growth Rate Est. (year over year) +14.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.07 +2.34%
on 02/28/22
26.90 -0.82%
on 03/04/22
+0.59 (+2.26%)
since 02/04/22
3-Month
11.70 +128.03%
on 12/06/21
26.90 -0.82%
on 03/04/22
+14.83 (+125.15%)
since 12/03/21
52-Week
11.03 +141.89%
on 11/30/21
26.90 -0.82%
on 03/04/22
+6.42 (+31.69%)
since 03/04/21

Most Recent Stories

More News
Zogenix To Present New Long-term Data on FINTEPLA® (fenfluramine) in Lennox-Gastaut Syndrome (LGS) at AAN 2022

Two podium and one poster presentation share important new findings on FINTEPLA’s safety profile and its impact on non-seizure related benefits for LGS...

ZGNX : 26.68 (+1.60%)
Zogenix (ZGNX) Reports Q4 Loss, Tops Revenue Estimates

Zogenix (ZGNX) delivered earnings and revenue surprises of -8.89% and 1.46%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

ZGNX : 26.68 (+1.60%)
DRRX : 1.2100 (-9.70%)
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

Total revenue of $26.6 million in the fourth quarter and $81.7 million for the full yearFINTEPLA® net product sales of $23.5 million in the fourth quarter...

ZGNX : 26.68 (+1.60%)
Zogenix (ZGNX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Zogenix (ZGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ZGNX : 26.68 (+1.60%)
Zogenix Supports New No-Cost Genetic Testing Program with United Mitochondrial Disease Foundation to Improve Diagnosis of Mitochondrial Diseases

Symptoms of mitochondrial diseases, such as Thymidine Kinase 2 deficiency (TK2d), can vary widely and mimic other rare and common diseases, making...

ZGNX : 26.68 (+1.60%)
Why Zogenix Flew Higher Before Leveling Off This Week

The company attracts a determined suitor from abroad.

ZGNX : 26.68 (+1.60%)
UCBJF : 122.0000 (+1.75%)
Biotech Stock Roundup: ZGNX's Acquisition News, REGN, BLUE's Updates & More

Regulatory and other pipeline updates from Zogenix (ZGNX) and Regeneron (REGN) are among a few key highlights from the biotech sector during the past week.

REGN : 962.49 (-0.39%)
ZGNX : 26.68 (+1.60%)
BLUE : 1.2800 (-6.23%)
GMDA : 0.0361 (-39.02%)
Zogenix (ZGNX) Stock Surges on Acquisition Offer From UCB

Belgium-based UCB is set to acquire Zogenix (ZGNX) for a total transaction value of $1.9 billion in cash. The transaction is likely to be completed by second-quarter 2022.

ALKS : 27.07 (-0.66%)
JAZZ : 120.42 (-0.07%)
ZGNX : 26.68 (+1.60%)
BNTX : 92.25 (-0.77%)
Zogenix (ZGNX) Stock Jumps 65.7%: Will It Continue to Soar?

Zogenix (ZGNX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

ZGNX : 26.68 (+1.60%)
Zogenix (ZGNX) Stock Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Zogenix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – ZGNX

Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Zogenix, Inc. (NASDAQ: ZGNX) to UCB is fair to Zogenix shareholders. Under the terms of the agreement, UCB would...

ZGNX : 26.68 (+1.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zogenix is a specialty biopharmaceutical company focused on developing therapies for patients with rare central nervous system conditions that have limited or no treatment options. The company is currently pursuing two therapies targeting the Dravet Syndrome and the Lennox-Gastaut Syndrome.

See More

Key Turning Points

3rd Resistance Point 27.27
2nd Resistance Point 27.09
1st Resistance Point 26.88
Last Price 26.68
1st Support Level 26.49
2nd Support Level 26.31
3rd Support Level 26.10

See More

52-Week High 26.90
Last Price 26.68
Fibonacci 61.8% 20.84
Fibonacci 50% 18.97
Fibonacci 38.2% 17.09
52-Week Low 11.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar